World Cardiology Conference 2026

Scientific Sessions

Cardiovascular Pharmacology

Understanding cardiovascular pharmacology is vital for evidence-based, safe, and effective treatment. At the World Cardiology Conference (WCC 2026), this session will review current and emerging drugs for hypertension, heart failure, lipid disorders, arrhythmias, and thrombosis. Topics include pharmacogenomics, drug-drug interactions in polypharmacy, and the role of SGLT2 inhibitors and GLP-1 agonists in cardio-metabolic care. Clinical trial data and real-world effectiveness studies will provide insights into optimal therapy selection.

Related Sessions

Cardiovascular Diseases
Interventional Cardiology
Heart Failure Management
Vascular Biology
Cardio-Oncology
Nuclear Cardiology
Congenital Heart Diseases
Geriatric Cardiology
Sports Cardiology
Genetic and Inherited Heart Diseases
Digital Cardiology and AI
Preventive Cardiology
Structural Heart Disease
Cardiovascular Pharmacology
Cardiac Electrophysiology and Arrhythmias
Paediatric Cardiology
Advanced Cardiac Imaging
Hypertension and Vascular Disorders
Lipidology and Atherosclerosis
Women’s Cardiovascular Health